Dr. Michael Wong discusses clinical workflows, dosing calculations, and biosafety protocols for the newly approved Tudriqev-nivolumab regimen.
Michael K. Wong, MD, PhD, FRCPC
Advertisement
Articles by Michael K. Wong, MD, PhD, FRCPC
Dr. Michael Wong of Roswell Park explains why melanoma survivors must prioritize skin barrier protection over tanning to prevent further UV injury.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses
2
Addressing Financial Toxicity: Team-Based Workflows in Oncology Care
3
Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses
4
SBRT Reduces Bowel Toxicity in Localized Intermediate-Risk Prostate Cancer
5